{"chebi_id":"9927","chebi_name":"valsartan","chebi_synonyms":["N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine","Diovan","N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine","(S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine","N-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine"],"diffprof_id_observed":["MTBLS7584_0002_00000003"],"diffprof_id_var_observed":[],"inchikey":"ACWBQPMHZXGDFX-QFIPXVFZSA-N","inn_name":"valsartan","iupac_name":"<em>N</em>-pentanoyl-<em>N</em>-{[2'-(1<em>H</em>-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-<small>L</small>-valine","num_study_observed":1,"reactome_ids":["R-HSA-162582","R-HSA-372790","R-HSA-373076","R-HSA-375276","R-HSA-500792"],"reactome_names":["Signal Transduction","Signaling by GPCR","Class A/1 (Rhodopsin-like receptors)","Peptide ligand-binding receptors","GPCR ligand binding"],"study_id_observed":["MTBLS7584"],"study_id_var_observed":[],"synonym_name":"<em>N</em>-(<em>p</em>-(<em>o</em>-1<em>H</em>-tetrazol-5-ylphenyl)benzyl)-<em>N</em>-valeryl-<small>L</small>-valine"}